JNJ Named Among Dividend Kings With 60-Plus Year Increase Streak
What happened
Johnson & Johnson appeared in a Motley Fool screen of dividend stocks considered candidates for long-term portfolio holding, published June 22, 2026. JNJ holds Dividend King status, having raised its dividend for more than 60 consecutive years. The company operates across pharmaceutical and medical technology segments following the 2023 spinoff of its consumer health unit into Kenvue. Shares closed at $230.61 on June 22, up 0.95% on the session.
The QL Read
With market breadth running at just 44% advancing and JNJ's QuantLogix composite at 62/100, the stock's defensive-dividend profile aligns with the cautious tape — reflecting steady factor conviction rather than a momentum surge.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.